In this case series, Burdier and colleagues describe the contrasting progress of cervical cancer screening programmes in Bhutan, India, and Türkiye, drawing on presentations from the CHIC South Asia Symposium (New Delhi, 2022). India, despite national VIA-based guidelines since 2016, reports only 1.9% ever-screened coverage among women aged 30–49, constrained by infrastructure gaps and absent […]
Country: Turkey
Cervical Cancer Screening Implementation in Turkey
Turkey transitioned in 2014 from Pap smear–based cervical cancer screening to a national HPV DNA–based program targeting women ≥30 years every five years. Dual sampling (HPV DNA plus reflex Pap smear) is analyzed centrally in a high-throughput mega-laboratory with real-time digital tracking and mobile result delivery. This centralized model increased screening coverage from